Veracyte Overview
Veracyte, Inc. is a global diagnostics company that provides high-value molecular tests to assist clinicians in diagnosing and treating various cancers, including thyroid, prostate, breast, bladder, and lung cancers, as well as interstitial lung diseases. Their tests, such as the Afirma Genomic Sequencing Classifier for thyroid cancer and the Decipher Prostate and Bladder tests, use advanced genomic technologies and machine learning to provide actionable insights. These insights help avoid unnecessary procedures and personalize treatment plans, improving patient outcomes and care efficiency. Veracyte Israel was established following the acquisition of Israeli cancer detection company C2i Genomics.
Latest News
No news articles.
Team Members
0
Employees: 1-10
Web & Social Links
Locations
Israel
6000 Shoreline Ct #300, South San Francisco, CA 94080, USA
Photos & Videos
No files yet
Veracyte Business
Sector
—Target Customer
—Core Technology
—Veracyte Financials
Veracyte Lifecycle
Veracyte News
0 articlesNo news articles.
Veracyte Team
No team members listed.
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Veracyte Internal
Recent Updates
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 54/100 |
| Missing | product stage, sector, tags, business model, homepage, video or image, funding rounds, news, markets, not claimed |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-01-10T00:00:00.000Z |
| Created | 2024-01-10T00:00:00.000Z |
| Status detail | Public on NASDAQ on Nov, 2013<br> |